Sumitomo Pharma America IS COMMITTED TO IMPROVING ACCESS TO GEMTESA
GEMTESA is covered for 69% of national commercial plans and covered for 85% of Medicare Part D Lives*†
For more information, please contact your GEMTESA Sales Representative.
All formulary data and access criteria are provided by Managed Markets Insights & Technology, LLC database as of October 2023. Nothing on this website is intended to serve as a guarantee of coverage or a guarantee of payment. For verification of coverage, please contact insurance plan.
*National commercial health plan formulary status under the pharmacy benefit updated as of October 2023.
†Data on file. Sumitomo Pharma America, Inc.
Personalized support for the GEMTESA treatment journey through:
- Tools that improve access to GEMTESA
- Resources that identify payor coverage among patients with OAB in the practice
- Insights for the office to help those who have a more challenging pathway to coverage
- Identification and addressing of barriers patients experience with regard to obtaining their prescribed medication, overcoming financial challenges, and getting started — and staying — on therapy
GEMTESA Simple
Savings Program
Copay information and patient support